Back to Search Start Over

Correction to: LHRH sparing therapy in patients with chemotherapy-naïve, mCRPC treated with abiraterone acetate plus prednisone: results of the randomized phase II SPARE trial.

Authors :
Ohlmann CH
Jäschke M
Jaehnig P
Krege S
Gschwend J
Rexer H
Junker K
Zillmann R
Rüssel C
Hellmis E
Suttmann H
Janssen M
Marin J
Hübner A
Mathers M
Gleißner J
Scheffler M
Feyerabend S
Telle J
Klier J
Stöckle M
Source :
Prostate cancer and prostatic diseases [Prostate Cancer Prostatic Dis] 2023 Dec; Vol. 26 (4), pp. 812.
Publication Year :
2023

Details

Language :
English
ISSN :
1476-5608
Volume :
26
Issue :
4
Database :
MEDLINE
Journal :
Prostate cancer and prostatic diseases
Accession number :
37253975
Full Text :
https://doi.org/10.1038/s41391-023-00682-2